TGFB1 and eosinophilic esophagitis: In humans, Fresolimumab, a monoclonal anti–TGF-β antibody, decreased biomarkers and reversed skin fibrosis in systemic sclerosis patients (Rice et al., 2015), however no studies have been carried out in EoE patients.